Clinical outcomes in >10,000 Asian vs >61,000 Non-Asian race patients with AF randomized to Warfarin vs DOACs: a patient-level meta-analyses from COMBINE AF

Back

ESC Professional Premium Access

Clinical outcomes in >10,000 Asian vs >61,000 Non-Asian race patients with AF randomized to Warfarin vs DOACs: a patient-level meta-analyses from COMBINE AF

Session: Risk assessment and prevention of brain infarction in atrial fibrillation

Topic: Oral Anticoagulation

Speaker: Doctor T. Chao (Taipei, TW)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)

4 presentations

0 follower

8 more presentations in this session

Incidence of silent brain injury in pacemaker implanted patients with atrial high-speed episodes (AHRE)

Speaker: Doctor M. Uyanik (Samsun, TR)

Altered fibrin clot properties and elevated von Willebrand Factors level are associated with progression to permanent atrial fibrillation during follow-up: a cohort study

Speaker: Doctor K. Nowak (Krakow, PL)

The triglyceride-glucose index is a marker of thromboembolic events in atrial fibrillation patient under oral anticoagulation therapy

Speaker: Doctor J. Rivera-Caravaca (Murcia, ES)

Resolution of silent left atrial thrombi and clinical outcomes in patients with atrial fibrillation: insight from the LAT trial

Speaker: Doctor N. Tanaka (Osaka, JP)

Evaluation of the biomarker-based ABC-AF-bleeding risk score and clinically based bleeding scores in 31,605 patients with atrial fibrillation treated with oral anticoagulation

Speaker: Associate Professor Z. Hijazi (Uppsala, SE)

Access the full session

Risk assessment and prevention of brain infarction in atrial fibrillation

Speakers: Doctor T. Chao, Doctor M. Uyanik, Doctor K. Nowak, Doctor J. Rivera-Caravaca, Doctor N. Tanaka...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources